Ormeval provides decision-support intelligence derived from public sources. It is not investment, medical, legal or regulatory advice, and states nothing about the value of any security. Forward figures are deterministic model estimates, not guidance.
Ormeval · Pharma intelligence · 28 SEP 2026
Pricing
Two products, Keytruda and Kisqali, are open to read in full, sourced and auditable, with no email. Everything else needs a plan. Workspace unlocks the whole catalog: the full forecast depth and private what-if scenarios, alerts, the weekly digest, the Ask Ormeval assistant (coming soon), the operator community and Comms Studio.
Our prices are public and per team - ask any per-seat vendor for theirs. The cost per person falls as your team grows.
Start here
Keytruda and Kisqali, open end-to-end, the full forecast funnel, HTA and market-access tables, exclusivity detail and every source. Worked examples you can audit, not a sample.
Workspace, Individual
For one operator: your own book, modelled, sourced and tracked.
Early access - no card collected today.
Small Team
or $12,500/year · flat, up to 5 people
Annual billing is ten months' price - two months free.
≈$2,500 per person / year at 5 people
Early access - no card collected today.
Built for the 2–5 person team that outgrew individual seats but isn't a full franchise yet.
Team Cockpit
or $37,500/year · Franchise band, up to 15 people
Annual billing is ten months' price - two months free.
≈$2,500 per person / year at 15 people
Early access - no card collected today.
Flat price for the whole team. No per-seat charges, ever.
Everything in Workspace, for the whole franchise. Priced by band, not per seat.
Flat band price, headcount picks the band, never a seat multiplier.
Early-access pricing, held for the first ten teams.
Security & trust, our DPA and the sub-processor register are public.
from $12,000/year
For pipelines, agents and internal tools that read Ormeval at machine scale. Annual capacity, never per record or per query; every call returns the cited record. From $12,000 a year for 10,000 calls; 50,000 calls $30,000; 250,000 calls $60,000; larger volumes by contract. Talk to us →
Priced in USD.
Per-seat incumbent (typical)
Custom quote (not published)
Ormeval Workspace (per operator)
$3,750/yr
Ormeval Franchise (per person at 15)
≈$2,500/yr
Early access, now open
Ormeval is early. We're inviting the first commercial teams to shape the roadmap. Trust here is not borrowed logos; it's that every figure is public, sourced and auditable.
Decision support you can cite in the boardroom, and check, line by line, against the source.
Questions, or want to cancel? Email us at hello@ormeval.com. A real person replies.
Two products, Keytruda and Kisqali, are open to read in full: the forecast funnel, the HTA and market-access tables, the exclusivity detail and every source. They are worked examples, not a sample. Everything else in the catalog needs a plan, along with private what-if scenarios, the Ask Ormeval assistant (coming soon), alerts, the weekly digest and export. Workspace is $375/month, or $3,750/year billed annually.
Per-seat pricing punishes a team for collaborating: the moment medical, market access and comms want the same picture, the bill goes up, so someone gets left off the licence and works from a stale screenshot. Ormeval prices by band, a flat fee for everyone up to the headcount cap, so the whole function works off one book and the cost per person falls as the team grows rather than rising.
Reported revenue, indications and milestone changes are public facts (company IR decks, SEC/EDGAR filings and regulator notices), each linked to its source. Your forecast assumptions are yours; the engine computes every figure deterministically. Every source is public, none is scraped, and no figure is AI-invented.
No. The assets you follow and the assumptions you set stay in your browser unless you choose to share them. Ormeval is decision support, not financial advice.
Yes, set for normal team use. Included each calendar month, per band: Workspace, 500 agent queries and 20 exports; Small Team, 2,500 agent queries and 100 exports; Franchise, 10,000 agent queries and 500 exports; Business Unit, 40,000 agent queries and 2,000 exports; Enterprise, by contract. Machine-scale use - pipelines, agents and internal tools reading the data continuously - is the Data / API licence.
Coming with the next release: 100 calls a month against the two open assets (Keytruda, Kisqali), with a key from your account and no card. It is not live yet.